ID: ALA104154

Max Phase: Preclinical

Molecular Formula: C9H15NO

Molecular Weight: 153.22

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  CCN1CC=C(C(C)=O)CC1

Standard InChI:  InChI=1S/C9H15NO/c1-3-10-6-4-9(5-7-10)8(2)11/h4H,3,5-7H2,1-2H3

Standard InChI Key:  OSMHAKPKSRJGTE-UHFFFAOYSA-N

Associated Targets(non-human)

Creatine transporter 104 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 153.22Molecular Weight (Monoisotopic): 153.1154AlogP: 1.23#Rotatable Bonds: 2
Polar Surface Area: 20.31Molecular Species: NEUTRALHBA: 2HBD: 0
#RO5 Violations: 0HBA (Lipinski): 2HBD (Lipinski): 0#RO5 Violations (Lipinski): 0
CX Acidic pKa: CX Basic pKa: 8.23CX LogP: 0.96CX LogD: 0.06
Aromatic Rings: 0Heavy Atoms: 11QED Weighted: 0.59Np Likeness Score: -0.17

References

1. Geldenhuys WJ, Lockman PR, McAfee JH, Fitzpatrick KT, Van der Schyf CJ, Allen DD..  (2004)  Molecular modeling studies on the active binding site of the blood-brain barrier choline transporter.,  14  (12): [PMID:15149650] [10.1016/j.bmcl.2004.04.020]

Source